Pharmovital ApS: Financial statements 2023
CVR: 27206506
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Pharmovital ApS (CVR 27206506) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,909,130 and a net result of DKK 1,029,654 compared with DKK 718,535 the year before. That is an increase of 15.3% compared with the year before. Equity in the 2023 report amounted to DKK 2,578,967. The solvency ratio was 40.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,909,130
- Profit/Loss
- DKK 1,029,654
- Equity
- DKK 2,578,967
- Total Assets
- DKK 6,427,602
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.9M | 1M | 2.6M | 3 |
| 2022 | - | 2.5M | 719K | 2.3M | 3 |
| 2021 | - | 1.1M | -772K | 1.9M | 3 |
| 2020 | - | 1.8M | 251K | 1.7M | 2 |
| 2019 | - | 2.3M | 807K | 1.6M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Pharmovital ApS
Pharmovital ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2003. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named GALLIVIT ApS and ApS KBIL 17 NR. 1578. The management consists of Kristian Krogh and Eskil Krogh. The company is owned by Eskro Holding ApS and Kr. Krogh Holding ApS. The company has 7 employees (2026). In 2026, the company reported a gross profit of DKK 8,519,379 and a net result of DKK 4,924,772 compared with DKK 586,153 the year before. Equity in the 2026 report amounted to DKK 8,743,173.